enVVeno Medical Corp Earnings Per Share (Diluted)
enVVeno Medical Corp (NVNO) reported Earnings Per Share (Diluted) of -$5.37 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-07-30
- enVVeno Medical Corp earnings per share, diluted for the quarter ending 2026-06-30 was -$5.37.
- enVVeno Medical Corp earnings per share, diluted for the quarter ending 2026-03-31 was -$5.89.
- enVVeno Medical Corp earnings per share, diluted for the quarter ending 2025-12-31 was $0.06, a 52.61% decline year-over-year.
- enVVeno Medical Corp earnings per share, diluted for the quarter ending 2025-09-30 was -$0.23.
- enVVeno Medical Corp earnings per share, diluted for fiscal 2025 was -$33.06.
- enVVeno Medical Corp earnings per share, diluted for fiscal 2024 was -$44.53.
- enVVeno Medical Corp earnings per share, diluted for fiscal 2023 was -$1.91.
- enVVeno Medical Corp earnings per share, diluted for fiscal 2022 was -$2.20.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 6 month as first filed | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month | Earnings Per Share, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$5.37 10-Q · filed 2026-07-30 | -$11.18 10-Q · filed 2026-07-30 | $0.59 derived: net income ÷ weighted average shares · filed 2026-07-30 | $1.70 derived: net income ÷ weighted average shares · filed 2026-07-30 | |||
| 2026-03-31 | -$5.89 10-Q · filed 2026-05-06 | $0.26 derived: net income ÷ weighted average shares · filed 2026-05-06 | $0.96 derived: net income ÷ weighted average shares · filed 2026-05-06 | $2.03 derived: net income ÷ weighted average shares · filed 2026-07-30 | |||
| 2025-12-31 | $0.06 derived: net income ÷ weighted average shares · filed 2026-03-26 | $0.43 derived: net income ÷ weighted average shares · filed 2026-03-26 | $1.19 derived: net income ÷ weighted average shares · filed 2026-07-30 | -$33.06 10-K · filed 2026-03-26 | |||
| 2025-09-30 | -$0.23 10-Q · filed 2025-10-30 | -$1.08 derived: net income ÷ weighted average shares · filed 2026-07-30 | -$0.78 10-Q · filed 2025-10-30 | $3.53 derived: net income ÷ weighted average shares · filed 2026-07-30 | |||
| 2025-06-30 | -$11.52 10-Q · filed 2026-07-30 | -$0.33 10-Q · filed 2025-07-31 | -$19.27 10-Q · filed 2026-07-30 | -$0.55 10-Q · filed 2025-07-31 | $1.16 derived: net income ÷ weighted average shares · filed 2026-07-30 | $3.18 derived: net income ÷ weighted average shares · filed 2026-07-30 | |
| 2025-03-31 | -$7.75 10-Q · filed 2026-05-06 | -$0.22 10-Q · filed 2025-04-30 | $0.47 derived: net income ÷ weighted average shares · filed 2026-05-06 | $1.66 derived: net income ÷ weighted average shares · filed 2026-05-06 | $6.31 derived: net income ÷ weighted average shares · filed 2026-05-06 | ||
| 2024-12-31 | $0.13 derived: net income ÷ weighted average shares · filed 2026-03-26 | $0.79 derived: net income ÷ weighted average shares · filed 2026-03-26 | $3.58 derived: net income ÷ weighted average shares · filed 2026-03-26 | -$44.53 10-K · filed 2026-03-26 | -$1.27 10-K · filed 2025-02-28 | ||
| 2024-09-30 | -$0.35 10-Q · filed 2025-10-30 | -$0.66 derived: net income ÷ weighted average shares · filed 2025-10-30 | -$0.97 10-Q · filed 2025-10-30 | -$1.33 derived: net income ÷ weighted average shares · filed 2025-10-30 | |||
| 2024-06-30 | -$0.31 10-Q · filed 2025-07-31 | -$0.62 10-Q · filed 2025-07-31 | -$0.98 derived: net income ÷ weighted average shares · filed 2025-07-31 | -$1.40 derived: net income ÷ weighted average shares · filed 2025-07-31 | |||
| 2024-03-31 | -$0.31 10-Q · filed 2025-04-30 | -$0.67 derived: net income ÷ weighted average shares · filed 2025-04-30 | -$1.10 derived: net income ÷ weighted average shares · filed 2025-04-30 | -$1.64 derived: net income ÷ weighted average shares · filed 2025-04-30 | |||
| 2023-12-31 | -$0.36 derived: net income ÷ weighted average shares · filed 2025-02-28 | -$0.80 derived: net income ÷ weighted average shares · filed 2025-02-28 | -$1.35 derived: net income ÷ weighted average shares · filed 2025-02-28 | -$1.91 10-K · filed 2025-02-28 | |||
| 2023-09-30 | -$0.45 10-Q · filed 2024-10-31 | -$1.02 derived: net income ÷ weighted average shares · filed 2024-10-31 | -$1.59 10-Q · filed 2024-10-31 | -$2.14 derived: net income ÷ weighted average shares · filed 2024-10-31 | |||
| 2023-06-30 | -$0.58 10-Q · filed 2024-07-31 | -$1.15 10-Q · filed 2024-07-31 | -$1.70 derived: net income ÷ weighted average shares · filed 2024-07-31 | -$2.24 derived: net income ÷ weighted average shares · filed 2024-07-31 | |||
| 2023-03-31 | -$0.57 10-Q · filed 2024-05-08 | -$1.12 derived: net income ÷ weighted average shares · filed 2024-05-08 | -$1.66 derived: net income ÷ weighted average shares · filed 2024-05-08 | -$2.29 derived: net income ÷ weighted average shares · filed 2024-05-08 | |||
| 2022-12-31 | -$0.55 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$1.09 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$1.72 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$2.20 10-K · filed 2024-02-29 | |||
| 2022-09-30 | -$0.54 10-Q · filed 2023-10-26 | -$1.17 derived: net income ÷ weighted average shares · filed 2023-10-26 | -$1.65 10-Q · filed 2023-10-26 | ||||
| 2022-06-30 | -$0.63 10-Q · filed 2023-07-31 | -$1.10 10-Q · filed 2023-07-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |